13F HOLDINGS REPORT
FCPM III SERVICES B.V.
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001193125-26-053151
Total Value
$762.9M
Positions
14
Other Managers
3
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 4,648,025 | $163.1M | 21.37% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 4,550,875 | $159.6M | 20.93% |
| 3 | DYNE THERAPEUTICS INC | DYN | 4,036,476 | $79.0M | 10.35% |
| 4 | RAPT THERAPEUTICS INC | 75382E208 | 1,833,333 | $62.1M | 8.14% |
| 5 | ENGENE HOLDINGS INC | ENGNW | 6,738,362 | $60.8M | 7.98% |
| 6 | MAPLIGHT THERAPEUTICS INC | MPLT | 3,226,400 | $56.7M | 7.43% |
| 7 | VOR BIOPHARMA INC | VOR | 3,617,354 | $47.3M | 6.20% |
| 8 | DYNE THERAPEUTICS INC | DYN | 1,426,370 | $27.9M | 3.66% |
| 9 | REPLIMUNE GROUP INC | REPL | 2,808,368 | $27.3M | 3.58% |
| 10 | ENGENE HOLDINGS INC | ENGNW | 2,894,199 | $26.1M | 3.43% |
| 11 | BICYCLE THERAPEUTICS PLC | BCYC | 3,468,430 | $24.6M | 3.22% |
| 12 | CRESCENT BIOPHARMA INC. | CBIO | 1,677,852 | $19.9M | 2.61% |
| 13 | ENGENE HOLDINGS INC | ENGNW | 2,403,072 | $7.1M | 0.93% |
| 14 | ENGENE HOLDINGS INC | ENGNW | 475,076 | $1.4M | 0.18% |